StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
Tweet
Share
E-mail
Get Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) 53% HIGHER; licensing deal with Teva Pharmaceutical Industries Ltd (NYSE: TEVA). Under the terms of the license and supply agreement, Alexza will receive an upfront cash payment of $40 million and is eligible to receive up to $195 million in additional milestone payments, based upon successful completion of the ADASUVE post-approval studies in the U.S. and achieving net sales targets. In addition, Teva will make tiered, royalty payments based on net commercial sales of ADASUVE.
Fusion-io (NYSE: FIO) 24% LOWER; announced that Shane Robison has been named Chairman, Chief Executive Officer and President, effective immediately. Mr. Robison, who is a director of the Fusion-io Board of Directors, succeeds David Flynn, who has resigned as CEO and President to pursue entrepreneurial investing activities. The company also announced that co-founder, Rick White, has resigned as Chief Marketing Officer to join Mr. Flynn in early stage investing activities. Messrs. Flynn and White will both remain members of the Board and will serve in advisory roles to the company for the next 12 months.
Oclaro (NASDAQ: OCLR) 20% LOWER; reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $141.6 million versus the consensus estimate of $148.14 million. Oclaro sees Q4 2013 revenue of $132-144 million, versus the consensus of $159.5 million
Synacor (NASDAQ: SYNC) 16% LOWER; reported Q1 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $29.1 million. Synacor sees FY2013 revenue of $122-126 million, versus the consensus of $123.2 million. Synacor sees Q2 2013 revenue of $26.5-27.5 million, versus the consensus of $30.6 million.
Market Leader, Inc. (Nasdaq: LEDR) 15% HIGHER; Trulia, Inc. (NYSE: TRLA) has entered into a definitive agreement to acquire Market Leader, Inc. for approximately $355 million, or an implied price of $11.33 per share.
WebMD Health Corp. (NASDAQ: WBMD) 15% HIGHER; reported Q1 EPS of $0.03, $0.18 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $115 million versus the consensus estimate of $106.64 million. WebMD Health Corp. sees FY2013 EPS of ($0.26)-(0.03), versus prior guidance of ($0.45)-(0.80) and the consensus of ($0.30). WebMD Health Corp. sees FY2013 revenue of $450-470 million, versus prior guidance of $430-455 million and the consensus of $444.01 million.
Valueclick, Inc. (NASDAQ: VCLK) 15% LOWER; reported Q1 EPS of $0.42, $0.02 better than the analyst estimate of $0.40. Revenue for the quarter came in at $165.4 million versus the consensus estimate of $166.7 million. Valueclick, Inc. sees Q2 2013 EPS of $0.38-0.40, versus the consensus of $0.41. Valueclick, Inc. sees Q2 2013 revenue of $164-168 million, versus the consensus of $175.6 million. Multiple downgrades.
Whole Foods Market, Inc. (NASDAQ: WFM) 9% HIGHER; reported Q2 EPS of $0.76, $0.03 better than the analyst estimate of $0.73. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.03 billion. Comparable store sales increased 6.9%, and identical store sales, excluding four relocations and one expansion, increased 6.6%. Sees FY2013 EPS of $2.86-$2.89, versus the consensus of $2.87. Also, announced today that it approved a two-for-one stock split.
Electronic Arts, Inc. (NASDAQ: EA) 8% HIGHER; reported Q4 EPS of $0.55, $0.03 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.04 billion. Electronic Arts, Inc. sees FY2014 EPS of $1.20, versus the consensus of $1.10. Electronic Arts, Inc. sees FY2014 revenue of $4 billion, versus the consensus of $4.1 billion. Electronic Arts, Inc. sees Q1 2014 EPS of $-0.62, versus the consensus of $-0.36. Electronic Arts, Inc. sees Q1 2014 revenue of $450 million, versus the consensus of $542.73 million.
Myriad Genetics, Inc. (NASDAQ: MYGN) 6% HIGHER; reported Q1 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $156.5 million versus the consensus estimate of $148.25 million.
CA, Inc. (NASDAQ: CA) 6% LOWER; reported Q4 EPS of $0.68, $0.12 better than the analyst estimate of $0.56. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.14 billion. CA will take a charge of approximately $150 Million in FY 2014 to rebalance resources with business priorities. CA, Inc. sees FY2014 EPS of $2.35-2.43, versus the consensus of $2.53. CA, Inc. sees FY2014 revenue of $4.43-4.52 billion, versus the consensus of $4.67 billion. Downgraded at Oppenheimer.
Symantec Corp (NASDAQ: SYMC) 6% LOWER; reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $1.75 billion versus the consensus estimate of $1.73 billion. Issues muted Q1 outlook.
Cognizant Technology Solutions (NASDAQ: CTSH) 6% HIGHER; reported Q1 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter rose 18.1% to $2.02 billion versus the consensus estimate of $2.01 billion. Cognizant Technology Solutions sees Q2 2013 EPS of $1.06, versus the consensus of $0.97. Cognizant Technology Solutions sees Q2 2013 revenue of $2.13 billion, versus the consensus of $2.11 billion. Cognizant Technology Solutions sees FY2013 EPS of $4.31, versus the consensus of $4.00. Cognizant Technology Solutions sees FY2013 revenue of $8.6 billion, versus the consensus of $8.63 billion.
C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) 5% LOWER; reported Q1 EPS of $0.64, $0.05 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $2.99 billion versus the consensus estimate of $2.98 billio
VIVUS, Inc. (NASDAQ: VVUS) 5% LOWER; reported Q1 EPS of ($0.53), $0.02 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $5.22 million.
AOL (NYSE: AOL) 5% LOWER; reported Q1 EPS of $0.32, $0.03 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $538.3 million versus the consensus estimate of $537.15 million.
SodaStream Int'l (NASDAQ: SODA) 5% LOWER; reported Q1 EPS of $0.68, $0.14 better than the analyst estimate of $0.54. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $113.11 million. The Company now expects full year 2013 revenue to increase approximately 27% over 2012 revenue of $436.3 million, up from its previous guidance of 25%. The Company now expects full year 2013 net income on an Adjusted basis, which excludes share-based compensation expense, to increase approximately 27% over the Adjusted net income of $50.0 million reported in 2012, up from its previous guidance of 25%.
Zillow, Inc. (NASDAQ: Z) 5% LOWER; reported Q1 EPS of ($0.11), $0.08 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $39 million versus the consensus estimate of $37.39 million. Record quarterly and all-time traffic, topping a record 52 million monthly unique users on mobile and Web in April 2013 (up 63% year-over-year), following a record 50 million monthly unique users in March 2013 (up 55% year-over-year). Sees FY2013 revenue of $178-$182 million, versus the consensus of $171.27 million. Downgraded at Goldman.
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) 4% HIGHER; reported Q1 EPS of ($0.19), $0.28 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $145.5 million versus the consensus estimate of $134.36 million.
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) 4% LOWER; reported Q1 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $196.2 million versus the consensus estimate of $189.92 million. Jazz Pharmaceuticals, Inc. sees FY2013 EPS of $6.10-6.30, versus the consensus of $5.87. Jazz Pharmaceuticals, Inc. sees FY2013 revenue of $830-860 million, versus the consensus of $825.5 million.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) 3% LOWER; announced today that it intends to offer for sale 9 million shares of its common stock in an underwritten public offering. $603.7 million versus the consensus estimate of $613.65 million.
Wendy's (Nasdaq: WEN) 3% LOWER; reported Q1 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $603.7 million versus the consensus estimate of $613.65 million. Wendy's North America Company-operated restaurants generated a same-store sales increase of 1.0 percent in the first quarter of 2013. Franchise same-store sales in North America increased 0.6 percent during the quarter. Wendy's sees FY2013 EPS of $0.20-0.22, versus prior guidance of $0.18-0.20 and the consensus of $0.19.
Orion Marine Group, Inc (NYSE: ORN) 3% HIGHER; upgraded to Outperform at FBR Capital
Lululemon Athletica Inc. (NASDAQ: LULU) font color="limegreen">3% HIGHER; upgraded to Buy at Sterne Agee
J. C. Penney Company, Inc. (NYSE: JCP) 2% HIGHER; Prelim. Q1 Revs Miss Views; Comps Fell 16.6%
DaVita HealthCare Partners Inc. (NYSE: DVA) 2% HIGHER; entered into a letter agreement (the “Standstill Agreement”) with Berkshire Hathaway Inc. (NYSE: BRK-A)(NYSE: BRK-B), on behalf of itself and its Affiliates (as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended) (collectively, “Investor”) pursuant to which Investor agreed, subject to certain exceptions and to the termination provisions specified in the Standstill Agreement, not to acquire beneficial ownership of the Company exceeding 25% of the Company’s then-outstanding Common Stock, and to certain other provisions respecting stockholders meetings, mergers and other matters specified therein.
Tripadvisor (NASDAQ: TRIP) 1% LOWER; reported Q1 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $229.9 million versus the consensus estimate of $223.76 million
Fusion-io (NYSE: FIO) 24% LOWER; announced that Shane Robison has been named Chairman, Chief Executive Officer and President, effective immediately. Mr. Robison, who is a director of the Fusion-io Board of Directors, succeeds David Flynn, who has resigned as CEO and President to pursue entrepreneurial investing activities. The company also announced that co-founder, Rick White, has resigned as Chief Marketing Officer to join Mr. Flynn in early stage investing activities. Messrs. Flynn and White will both remain members of the Board and will serve in advisory roles to the company for the next 12 months.
Oclaro (NASDAQ: OCLR) 20% LOWER; reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $141.6 million versus the consensus estimate of $148.14 million. Oclaro sees Q4 2013 revenue of $132-144 million, versus the consensus of $159.5 million
Synacor (NASDAQ: SYNC) 16% LOWER; reported Q1 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $29.1 million. Synacor sees FY2013 revenue of $122-126 million, versus the consensus of $123.2 million. Synacor sees Q2 2013 revenue of $26.5-27.5 million, versus the consensus of $30.6 million.
Market Leader, Inc. (Nasdaq: LEDR) 15% HIGHER; Trulia, Inc. (NYSE: TRLA) has entered into a definitive agreement to acquire Market Leader, Inc. for approximately $355 million, or an implied price of $11.33 per share.
WebMD Health Corp. (NASDAQ: WBMD) 15% HIGHER; reported Q1 EPS of $0.03, $0.18 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $115 million versus the consensus estimate of $106.64 million. WebMD Health Corp. sees FY2013 EPS of ($0.26)-(0.03), versus prior guidance of ($0.45)-(0.80) and the consensus of ($0.30). WebMD Health Corp. sees FY2013 revenue of $450-470 million, versus prior guidance of $430-455 million and the consensus of $444.01 million.
Valueclick, Inc. (NASDAQ: VCLK) 15% LOWER; reported Q1 EPS of $0.42, $0.02 better than the analyst estimate of $0.40. Revenue for the quarter came in at $165.4 million versus the consensus estimate of $166.7 million. Valueclick, Inc. sees Q2 2013 EPS of $0.38-0.40, versus the consensus of $0.41. Valueclick, Inc. sees Q2 2013 revenue of $164-168 million, versus the consensus of $175.6 million. Multiple downgrades.
Whole Foods Market, Inc. (NASDAQ: WFM) 9% HIGHER; reported Q2 EPS of $0.76, $0.03 better than the analyst estimate of $0.73. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.03 billion. Comparable store sales increased 6.9%, and identical store sales, excluding four relocations and one expansion, increased 6.6%. Sees FY2013 EPS of $2.86-$2.89, versus the consensus of $2.87. Also, announced today that it approved a two-for-one stock split.
Electronic Arts, Inc. (NASDAQ: EA) 8% HIGHER; reported Q4 EPS of $0.55, $0.03 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.04 billion. Electronic Arts, Inc. sees FY2014 EPS of $1.20, versus the consensus of $1.10. Electronic Arts, Inc. sees FY2014 revenue of $4 billion, versus the consensus of $4.1 billion. Electronic Arts, Inc. sees Q1 2014 EPS of $-0.62, versus the consensus of $-0.36. Electronic Arts, Inc. sees Q1 2014 revenue of $450 million, versus the consensus of $542.73 million.
Myriad Genetics, Inc. (NASDAQ: MYGN) 6% HIGHER; reported Q1 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $156.5 million versus the consensus estimate of $148.25 million.
CA, Inc. (NASDAQ: CA) 6% LOWER; reported Q4 EPS of $0.68, $0.12 better than the analyst estimate of $0.56. Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.14 billion. CA will take a charge of approximately $150 Million in FY 2014 to rebalance resources with business priorities. CA, Inc. sees FY2014 EPS of $2.35-2.43, versus the consensus of $2.53. CA, Inc. sees FY2014 revenue of $4.43-4.52 billion, versus the consensus of $4.67 billion. Downgraded at Oppenheimer.
Symantec Corp (NASDAQ: SYMC) 6% LOWER; reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $1.75 billion versus the consensus estimate of $1.73 billion. Issues muted Q1 outlook.
Cognizant Technology Solutions (NASDAQ: CTSH) 6% HIGHER; reported Q1 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter rose 18.1% to $2.02 billion versus the consensus estimate of $2.01 billion. Cognizant Technology Solutions sees Q2 2013 EPS of $1.06, versus the consensus of $0.97. Cognizant Technology Solutions sees Q2 2013 revenue of $2.13 billion, versus the consensus of $2.11 billion. Cognizant Technology Solutions sees FY2013 EPS of $4.31, versus the consensus of $4.00. Cognizant Technology Solutions sees FY2013 revenue of $8.6 billion, versus the consensus of $8.63 billion.
C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) 5% LOWER; reported Q1 EPS of $0.64, $0.05 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $2.99 billion versus the consensus estimate of $2.98 billio
VIVUS, Inc. (NASDAQ: VVUS) 5% LOWER; reported Q1 EPS of ($0.53), $0.02 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $5.22 million.
AOL (NYSE: AOL) 5% LOWER; reported Q1 EPS of $0.32, $0.03 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $538.3 million versus the consensus estimate of $537.15 million.
SodaStream Int'l (NASDAQ: SODA) 5% LOWER; reported Q1 EPS of $0.68, $0.14 better than the analyst estimate of $0.54. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $113.11 million. The Company now expects full year 2013 revenue to increase approximately 27% over 2012 revenue of $436.3 million, up from its previous guidance of 25%. The Company now expects full year 2013 net income on an Adjusted basis, which excludes share-based compensation expense, to increase approximately 27% over the Adjusted net income of $50.0 million reported in 2012, up from its previous guidance of 25%.
Zillow, Inc. (NASDAQ: Z) 5% LOWER; reported Q1 EPS of ($0.11), $0.08 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $39 million versus the consensus estimate of $37.39 million. Record quarterly and all-time traffic, topping a record 52 million monthly unique users on mobile and Web in April 2013 (up 63% year-over-year), following a record 50 million monthly unique users in March 2013 (up 55% year-over-year). Sees FY2013 revenue of $178-$182 million, versus the consensus of $171.27 million. Downgraded at Goldman.
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) 4% HIGHER; reported Q1 EPS of ($0.19), $0.28 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $145.5 million versus the consensus estimate of $134.36 million.
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) 4% LOWER; reported Q1 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $196.2 million versus the consensus estimate of $189.92 million. Jazz Pharmaceuticals, Inc. sees FY2013 EPS of $6.10-6.30, versus the consensus of $5.87. Jazz Pharmaceuticals, Inc. sees FY2013 revenue of $830-860 million, versus the consensus of $825.5 million.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) 3% LOWER; announced today that it intends to offer for sale 9 million shares of its common stock in an underwritten public offering. $603.7 million versus the consensus estimate of $613.65 million.
Wendy's (Nasdaq: WEN) 3% LOWER; reported Q1 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $603.7 million versus the consensus estimate of $613.65 million. Wendy's North America Company-operated restaurants generated a same-store sales increase of 1.0 percent in the first quarter of 2013. Franchise same-store sales in North America increased 0.6 percent during the quarter. Wendy's sees FY2013 EPS of $0.20-0.22, versus prior guidance of $0.18-0.20 and the consensus of $0.19.
Orion Marine Group, Inc (NYSE: ORN) 3% HIGHER; upgraded to Outperform at FBR Capital
Lululemon Athletica Inc. (NASDAQ: LULU) font color="limegreen">3% HIGHER; upgraded to Buy at Sterne Agee
J. C. Penney Company, Inc. (NYSE: JCP) 2% HIGHER; Prelim. Q1 Revs Miss Views; Comps Fell 16.6%
DaVita HealthCare Partners Inc. (NYSE: DVA) 2% HIGHER; entered into a letter agreement (the “Standstill Agreement”) with Berkshire Hathaway Inc. (NYSE: BRK-A)(NYSE: BRK-B), on behalf of itself and its Affiliates (as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended) (collectively, “Investor”) pursuant to which Investor agreed, subject to certain exceptions and to the termination provisions specified in the Standstill Agreement, not to acquire beneficial ownership of the Company exceeding 25% of the Company’s then-outstanding Common Stock, and to certain other provisions respecting stockholders meetings, mergers and other matters specified therein.
Tripadvisor (NASDAQ: TRIP) 1% LOWER; reported Q1 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $229.9 million versus the consensus estimate of $223.76 million
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Warren Buffett, Sterne AgeeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
